
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, I will follow the outlined steps:<br><br>### Step 1: List the Key Functional Markers<br>- **PIGR (Polymeric Immunoglobulin Receptor):** Involved in the transcytosis of polymeric immunoglobulin across epithelial cells.<br>- **ALDH1A3 (Aldehyde Dehydrogenase 1 Family Member A3):** Plays a role in the oxidation of aldehydes and is often associated with stem cell properties and cancer stem cells.<br>- **SAA1/SAA2 (Serum Amyloid A1/A2):** Acute-phase proteins involved in inflammation.<br>- **CXCL1/CXCL2/CXCL3/CXCL8 (Chemokine Ligands):** Involved in chemotaxis and inflammatory responses.<br>- **MMP7 (Matrix Metallopeptidase 7):** Involved in the breakdown of extracellular matrix, important in tissue remodeling and cancer metastasis.<br>- **SOD2 (Superoxide Dismutase 2):** Mitochondrial enzyme that protects against oxidative stress.<br>- **MT2A/MT1X (Metallothioneins):** Involved in metal ion homeostasis and protection against oxidative damage.<br>- **S100A9/S100A6/S100A16 (S100 Calcium Binding Proteins):** Involved in regulation of a variety of cellular processes such as cell cycle progression and differentiation.<br>- **CCL20 (C-C Motif Chemokine Ligand 20):** Involved in immune responses and inflammation.<br>- **BIRC3 (Baculoviral IAP Repeat Containing 3):** Involved in inhibiting apoptosis.<br>- **TNFRSF12A (Tumor Necrosis Factor Receptor Superfamily Member 12A):** Involved in cell survival and inflammation.<br><br>### Step 2: List the Key Cell Type Markers<br>- **KRT7 (Keratin 7):** Typically expressed in epithelial cells, including ductal and glandular epithelia.<br>- **KRT23 (Keratin 23):** Associated with epithelial cells.<br>- **LCN2 (Lipocalin 2):** Often expressed in epithelial cells and involved in innate immunity.<br>- **SLPI (Secretory Leukocyte Peptidase Inhibitor):** Expressed in epithelial cells, involved in protecting epithelial tissues from proteolytic damage.<br>- **WFDC2 (WAP Four-Disulfide Core Domain 2):** Also known as HE4, expressed in epithelial cells, particularly in reproductive tissues.<br>- **ANXA1/ANXA3 (Annexins):** Involved in membrane-related events along exocytotic and endocytotic pathways, often expressed in epithelial cells.<br><br>### Step 3: Cross-reference Known Databases<br>Using databases such as the Human Protein Atlas, CellMarker, and literature on scRNA-seq datasets, the markers listed are predominantly associated with epithelial cells, particularly those involved in immune response, inflammation, and cancer-related pathways.<br><br>### Step 4: Determine the Most Probable General Cell Type<br>Based on the expression of markers such as KRT7, KRT23, and WFDC2, the most probable general cell type is **epithelial cells**. These markers are commonly expressed in epithelial tissues, including those found in the breast.<br><br>### Step 5: Identify the Top 3 Most Probable Sub Cell Types<br>1. **Luminal Epithelial Cells:** Characterized by the expression of keratins such as KRT7 and markers like WFDC2, which are often found in luminal epithelial cells of the breast.<br>2. **Basal/Myoepithelial Cells:** While less likely due to the lack of specific basal markers, some overlap in markers like S100 proteins could suggest a basal phenotype.<br>3. **Cancer Stem-like Cells:** The presence of ALDH1A3 and other stemness-related markers could indicate a subpopulation with stem-like properties within the epithelial compartment.<br><br>The most likely subtype, given the context of breast cancer tissue and the expression of KRT7, WFDC2, and ALDH1A3, is **Luminal Epithelial Cells**.<br><br>### Step 6: Provide a Concise Summary of Your Analysis<br>The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of epithelial cells, specifically luminal epithelial cells. This conclusion is supported by the expression of key epithelial markers such as KRT7 and WFDC2, along with functional markers related to inflammation and cancer pathways. The presence of ALDH1A3 also suggests a potential cancer stem-like subpopulation within the epithelial cells.<br><br>FINAL ANNOTATION COMPLETED
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED<br><br>The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:<br><br>1. **Marker Consistency:**<br>   - The key functional markers and cell type markers listed in the annotation are present in the provided marker list. <br>   - The markers such as KRT7, KRT23, and WFDC2 are indeed associated with epithelial cells, particularly luminal epithelial cells, which aligns with the annotation of the cell type as epithelial cells.<br><br>2. **Mixed Cell Type Consideration:**<br>   - The annotation acknowledges the potential presence of cancer stem-like cells due to the expression of ALDH1A3, which is appropriate given the context of breast cancer tissue. <br>   - There is no strong evidence of multiple distinct cell types that would necessitate flagging for mixed cell type consideration beyond what has been addressed.<br><br>The annotation is well-supported by the marker list and the context of breast cancer tissue, leading to a logical conclusion of luminal epithelial cells as the primary cell type.
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">Epithelial Cells</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>Luminal Epithelial Cells</li><li>Basal/Myoepithelial Cells</li><li>Cancer Stem-like Cells</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">85</div>
                        <div class="scoring-content">
                            The annotation results provided for the single-cell dataset derived from human breast cancer tissue are generally well-executed, with a few areas that could be improved. <br><br>1. **Correctness of Annotations:**<br>   - The annotation correctly identifies the main cell type as epithelial cells, which is consistent with the presence of markers such as KRT7, KRT23, and WFDC2. These markers are well-known to be associated with epithelial cells, particularly in the context of breast tissue.<br>   - The identification of luminal epithelial cells as the most probable sub cell type is appropriate given the expression of KRT7 and WFDC2, which are typically found in luminal epithelial cells of the breast.<br><br>2. **Balanced Consideration of Multiple Markers:**<br>   - The annotation does a good job of considering a range of markers, including those related to inflammation (e.g., CXCL1, CXCL8), cancer pathways (e.g., MMP7, ALDH1A3), and epithelial identity (e.g., KRT7, WFDC2). This balanced approach helps in capturing the complexity of the cell population.<br>   - However, there is a slight overemphasis on ALDH1A3 as an indicator of cancer stem-like cells. While ALDH1A3 is indeed associated with stemness, the presence of this marker alone may not be sufficient to definitively identify a cancer stem-like subpopulation without additional supporting markers.<br><br>3. **Ability to Capture the General Picture:**<br>   - The annotation provides a comprehensive view of the cell types present, acknowledging the potential presence of cancer stem-like cells and basal/myoepithelial cells. This reflects an understanding of the heterogeneity within breast cancer tissues.<br>   - The annotation could have benefited from a more explicit discussion of the rank and importance of the markers. For instance, PIGR, which appears first, is not given as much emphasis in the final annotation, despite its potential significance in epithelial cell function.<br><br>4. **Potential Misclassifications or Oversights:**<br>   - There are no obvious misclassifications, but the annotation could have explored the potential for mixed cell types more thoroughly, given the diverse range of markers present.<br><br>Overall, the annotation is scientifically accurate and provides a well-rounded view of the cell populations, with minor areas for improvement in marker emphasis and exploration of mixed cell types.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    